24 Jan 2017
Low homoarginine (HA) is an emerging biomarker for cardiovascular diseases. In collaboration, Dorothee Atzler from the Vascular Biology team at the ISD showed that HA is more than a bystander biomarker, since HA-supplementation helps to support cardiac function in chronic heart failure in mice. The findings suggest that HA-supplementation is a promising approach for clinical translation.
Dr. Dorothee Atzler finished post-doctoral training at Oxford University last year and now is an LMU excellence fellow at the ISD.